Kenneth P. Roos

Molecular Biology · 2007

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Kenneth P. Roos trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain (in Molecular Biology)

Papers from Kenneth P. Roos's perspective

Ordered by how strongly the researchers Kenneth P. Roos trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  2. Opinion: Angiogenesis: an organizing principle for drug discovery? (Nature reviews. Drug discovery)
  3. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. (Journal of Clinical Investigation)
  4. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. (American Journal of Physiology. Heart and Circulatory Physiology)
  5. Angiogenesis in life, disease and medicine (Nature)
  6. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. (American Journal of Pathology)
  7. Sorafenib in advanced clear-cell renal-cell carcinoma. (New England Journal of Medicine)
  8. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. (Journal of Clinical Oncology)
  9. Clinical translation of angiogenesis inhibitors (Nature Reviews. Cancer)
  10. Origins of circulating endothelial cells and endothelial outgrowth from blood. (Journal of Clinical Investigation)

Their papers